Skip to main content

Aging and Cellular Fate: Senescence, Death, or Cancer

Edited by:
Cristophe Nicot: 
Kansas University Medical Center, USA

Submission Status: Open   |   Submission Deadline: 29th February 2024


Molecular Cancer is calling for submissions to our Collection on 'Aging and Cellular Fate: Senescence, Death, or Cancer.'

This Collection aims to unravel complex interplay between cellular aging processes, such as senescence and apoptosis, and their impact on cancer initiation, progression, and therapeutic responses.

About the collection

Molecular Cancer is calling for submissions to our Collection on 'Aging and Cellular Fate: Senescence, Death, or Cancer.'

This Collection aims to unravel complex interplay between cellular aging processes, such as senescence and apoptosis, and their impact on cancer initiation, progression, and therapeutic responses. We welcome original research, reviews shedding light on the molecular mechanisms underlying these cellular decisions and their roles in aging and cancer diseases, and their potential manipulation for therapeutic interventions. 

Image credit: © Gabriel / Generated with AI / Stock.adobe.com

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. 

Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Aging and Cellular Fate: Senescence, Death, or Cancer" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.